Literature DB >> 1233255

Plasma protein binding of phenylbutazone during recovery from acute renal failure.

M M Mussche, F M Belpaire, M G Bogaert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1233255     DOI： 10.1007/bf00613431

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  Decreased drug binding by serum albumin during renal failure.

Authors:  D S Campion
Journal:  Toxicol Appl Pharmacol       Date:  1973-07       Impact factor: 4.219

2.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

3.  The effect of dialysis on the protein binding of drugs in the plasma of patients with acute renal failure.

Authors:  F Andreasen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-04

4.  Determination of furosemide in blood plasma and its binding to proteins in normal plasma and in plasma from patients with acute renal failure.

Authors:  F Andreasen; P Jakobsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-07

5.  Influence of disease on binding of drugs to plasma proteins.

Authors:  M M Reidenberg; M Affrime
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

6.  Protein binding of drugs in plasma from patients with acute renal failure.

Authors:  F Andreasen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1973

7.  Interindividual differences in the protein binding of sulfonamides: the effect of disease and drugs.

Authors:  A H Anton; W T Corey
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

8.  The effect of haemodialysis on the binding capacity of albumin.

Authors:  S H Dromgoole
Journal:  Clin Chim Acta       Date:  1973-07-27       Impact factor: 3.786
  8 in total
  7 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors:  H Kurz
Journal:  Klin Wochenschr       Date:  1978-12-15

3.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

4.  Investigations on salicylate protein binding in newborns and infants.

Authors:  A Windorfer; D Karitzky; U Gasteiger; K Stehr
Journal:  Eur J Pediatr       Date:  1978-03-13       Impact factor: 3.183

Review 5.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

6.  Influence of acute renal failure on the protein binding of drugs in animals and in man.

Authors:  F M Belpaire; M G Bogaert; M M Mussche
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.